Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 09/09/2026 5-day change 1st Jan Change
17.96 CNY -0.88% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +0.67% -4.32%

Valuation : Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 8.16B 1.22B 1.05B 985M 897M 1.68B 116B 1.69B 11.67B 4.51B 58.91B 4.56B 4.46B 187B P/E 2026 *
19.5x
P/E 2027 * 16.6x
Enterprise Value 8.66B 1.29B 1.11B 1.05B 953M 1.78B 123B 1.79B 12.39B 4.79B 62.55B 4.84B 4.74B 198B EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.02x
Free-Float
51.96%
Yield 2026 *
1.67%
Yield 2027 * 2.67%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-10 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-27 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
30/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
14/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day-0.88%
1 week+0.67%
Current month+3.82%
1 month-1.32%
3 months+17.00%
6 months-6.31%
Current year-4.32%
1 week 17.18
Extreme 17.18
18.33
1 month 16.59
Extreme 16.59
20.26
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
22.96
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 30/03/2023
Director of Finance/CFO 51 28/04/2022
Corporate Officer/Principal 45 27/10/2020
Director TitleAgeSince
Chairman 63 12/05/2008
Director/Board Member 53 25/12/2019
Director/Board Member 51 10/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
5/24/23 A Buy 3,000 0.0009%
5/23/23 A Buy 1,000 0.0003%
9/4/20 A Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%+0.67%-17.31%-0.44% 1.23B
-0.34%-3.75%-51.06%-60.54% 30.4B
-1.75%-4.58%+25.53%+103.19% 11.98B
+1.47%+7.06%-8.77%+9.28% 4.05B
-2.53%-4.50%-5.38%+16.01% 3.08B
-1.77%-0.89%+50.43%+33.33% 2.02B
+1.18%-0.72%+10.31%+18.86% 1.87B
-1.37%-7.82%-10.74%+192.76% 1.51B
-0.83%+5.78%-4.16%-37.53% 1.1B
-1.34%-4.86%-8.90%-21.30% 911M
Average -0.82%-1.18%-2.00%+25.36% 5.81B
Weighted average by Cap. -0.68%-2.83%-21.11%-3.17%

Financials

2026 *2027 *
Net sales 3.73B 556M 479M 451M 411M 769M 52.95B 772M 5.34B 2.07B 26.97B 2.09B 2.04B 85.45B 4.21B 627M 539M 508M 463M 866M 59.66B 869M 6.02B 2.33B 30.39B 2.35B 2.3B 96.28B
Net income 428M 63.81M 54.91M 51.7M 47.11M 88.14M 6.07B 88.49M 613M 237M 3.09B 240M 234M 9.8B 504M 75.12M 64.64M 60.87M 55.46M 104M 7.15B 104M 721M 279M 3.64B 282M 276M 11.54B
Net Debt 503M 74.9M 64.45M 60.69M 55.3M 103M 7.13B 104M 719M 278M 3.63B 281M 275M 11.5B 339M 50.49M 43.44M 40.91M 37.27M 69.74M 4.8B 70.01M 485M 187M 2.45B 190M 185M 7.75B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
09/09/26 CN¥17.96 -0.88% 3,982,576
08/09/26 CN¥18.12 -0.33% 5,210,100
07/09/26 CN¥18.18 +2.77% 8,482,000
04/09/26 CN¥17.69 +2.49% 5,348,900
03/09/26 CN¥17.26 -3.25% 4,850,800
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
17.96CNY
Average target price
20.41CNY
Spread / Average Target
+13.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!